Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. Hydrocephalus shunts allow excess cerebrospinal fluid (CSF) to drain to another area of the body. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hydrocephalus shunts market in Sweden. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the hydrocephalus shunts market in Sweden was Aesculap followed by Integra LifeSciences, Medtronic, Sophysa and Spiegelberg.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Hydrocephalus valves and hydrocephalus catheters are covered in this category. Hydrocephalus valves regulate the flow of CSF out of the brain’s ventricles. Two types of hydrocephalus catheters are considered in the market: antimicrobial catheters and standard catheters.

The hydrocephalus shunts market in Sweden can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size hydrocephalus shunts in Sweden, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.